Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$17,312,832
+$1,337,105 QoQ
Shares Held
68,800
-6.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.44%
of 13F equity value
Holder Rank
#673
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CULLINAN ASSOCIATES INC holds $90,482,569 across 10 Drug Manufacturers - General names. ABBV ranks #2 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
177,028 | $44,959,801 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
68,800 | $17,312,832 | |
| 3 | AMGN |
Amgen Inc
|
24,288 | $8,795,170 | |
| 4 | LLY |
ELI LILLY & Co
|
6,866 | $8,235,287 | |
| 5 | MRK |
Merck & Co., Inc.
|
46,620 | $5,990,670 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
40,190 | $2,315,747 | |
| 7 | PFE |
Pfizer Inc
|
51,301 | $1,235,328 | |
| 8 | NVS |
Novartis AG
|
4,700 | $736,584 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,312,832 | 68,800 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $15,975,727 | 73,455 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $19,050,353 | 83,375 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $19,631,350 | 84,786 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $16,361,103 | 88,143 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $19,216,336 | 91,716 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $16,664,172 | 93,777 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $21,604,706 | 109,402 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $20,686,684 | 120,608 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $23,147,823 | 127,116 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $20,209,792 | 130,411 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $22,521,624 | 151,091 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $18,574,551 | 137,865 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $21,133,099 | 132,604 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $20,285,933 | 125,524 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $16,316,849 | 121,577 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $19,189,569 | 125,291 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $18,990,538 | 117,146 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $17,255,782 | 127,443 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $9,773,237 | 90,602 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $8,813,967 | 78,249 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $5,897,124 | 54,492 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $1,481,991 | 13,831 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $624,604 | 7,131 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $876,845 | 8,931 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $525,711 | 6,900 | Shares | Sole | 2020-04-01 | |
| No filing history on record for this holder in this stock. | ||||||